News In Brief
This article was originally published in The Gray Sheet
Executive Summary
Abbott’s RX Acculink
You may also be interested in...
Gore's PFO Closers REDUCE Recurrent Ischemic Strokes By 77% In Trial
REDUCE is the first trial of patent foramen ovale closure device to show statistically significant reduction in stroke recurrence in its primary intent-to-treat analysis. The results, presented at the European Stroke Organisation Conference in Prague, will support Gore's application for Cardioform to the US FDA by the end of the year.
Medicare Panel Looks To Upcoming Study To Fill Evidence Gaps For Carotid Artery Disease
There's a lot more to learn about which treatment to choose for carotid atherosclerosis patients, Medicare advisors said this week. A new trial in the works that would compare both surgery and stenting to standalone medical therapy presents a good opportunity to fill the gaps.
Medicare Panel Looks To Upcoming Study To Fill Evidence Gaps For Carotid Artery Disease
There's a lot more to learn about which treatment to choose for carotid atherosclerosis patients, Medicare advisors said this week. A new trial in the works that would compare both surgery and stenting to standalone medical therapy presents a good opportunity to fill the gaps.